Frailty Subgroups Determine Heterogeneous Outcomes in Elderly Patients with Newly-Diagnosed Multiple Myeloma- Long-Term Follow-up of the HOVON 143 Trial

Febe Smits; Kaz Groen; Mark-David Levin; Claudia A. M. Stege; Roel J. W. van Kampen; Ellen van der Spek; Yavuz M. Bilgin; Noortje Thielen; Inger S. Nijhof; Inge Ludwig; Esther G. M. De Waal; Yorick Sandberg; Alain Kentos; Gert Jan Timmers; Josien C. Regelink; Matthijs Westerman; Koen de Heer; Marie Christiane Vekemans; Nazik Durdu-Rayman; Nicole de Graauw; Maarten R. Seefat; Niels W. C. J. van de Donk; Paula F. Ypma; Kazem Nasserinejad; Sonja Zweegman

doi:10.1182/blood-2024-208754

Frailty Subgroups Determine Heterogeneous Outcomes in Elderly Patients with Newly-Diagnosed Multiple Myeloma- Long-Term Follow-up of the HOVON 143 Trial

Febe Smits
, Kaz Groen
, Mark-David Levin
, Claudia A. M. Stege
, Roel J. W. van Kampen
, Ellen van der Spek
, Yavuz M. Bilgin
, Noortje Thielen
, Inger S. Nijhof
, Inge Ludwig
, Esther G. M. De Waal
, Yorick Sandberg
, Alain Kentos
, Gert Jan Timmers
, Josien C. Regelink
, Matthijs Westerman
, Koen de Heer
, Marie Christiane Vekemans
, Nazik Durdu-Rayman
, Nicole de Graauw

Maarten R. Seefat, Niels W. C. J. van de Donk, Paula F. Ypma, Kazem Nasserinejad, Sonja Zweegman

Hematology

University of Amsterdam
Haga Hospital
Zuyderland MC, Quality and Safety
Rijnstate Hospital
Diakonessenhuis
St. Antonius Ziekenhuis
Dept Neurol & Neurophysiol
Medical Centre Leeuwarden
Groupe Jolimont
Dept Internal Med
Université catholique de Louvain

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

2 Citations (Web of Science)

39 Downloads (Pure)

Original language	English
Pages (from-to)	4739-4740
Number of pages	2
Journal	Blood
Volume	144
DOIs	https://doi.org/10.1182/blood-2024-208754
Publication status	Published - 5 Nov 2024

Access to Document

10.1182/blood-2024-208754

blood-7497-mainFinal published version, 434 KBLicence: Article 25fa Dutch Copyright Act

Cite this

Smits, F., Groen, K., Levin, M.-D., Stege, C. A. M., Kampen, R. J. W. V., van der Spek, E., Bilgin, Y. M., Thielen, N., Nijhof, I. S., Ludwig, I., Waal, E. G. M. D., Sandberg, Y., Kentos, A., Timmers, G. J., Regelink, J. C., Westerman, M., de Heer, K., Vekemans, M. C., Durdu-Rayman, N., ... Zweegman, S. (2024). Frailty Subgroups Determine Heterogeneous Outcomes in Elderly Patients with Newly-Diagnosed Multiple Myeloma- Long-Term Follow-up of the HOVON 143 Trial. Blood, 144, 4739-4740. https://doi.org/10.1182/blood-2024-208754

@article{f1f6a8845ef74ac483f5150eec5f2d41,

title = "Frailty Subgroups Determine Heterogeneous Outcomes in Elderly Patients with Newly-Diagnosed Multiple Myeloma- Long-Term Follow-up of the HOVON 143 Trial",

author = "Febe Smits and Kaz Groen and Mark-David Levin and Stege, \{Claudia A. M.\} and Kampen, \{Roel J. W. van\} and \{van der Spek\}, Ellen and Bilgin, \{Yavuz M.\} and Noortje Thielen and Nijhof, \{Inger S.\} and Inge Ludwig and Waal, \{Esther G. M. De\} and Yorick Sandberg and Alain Kentos and Timmers, \{Gert Jan\} and Regelink, \{Josien C.\} and Matthijs Westerman and \{de Heer\}, Koen and Vekemans, \{Marie Christiane\} and Nazik Durdu-Rayman and \{de Graauw\}, Nicole and Seefat, \{Maarten R.\} and Donk, \{Niels W. C. J. van de\} and Ypma, \{Paula F.\} and Kazem Nasserinejad and Sonja Zweegman",

year = "2024",

month = nov,

day = "5",

doi = "10.1182/blood-2024-208754",

language = "English",

volume = "144",

pages = "4739--4740",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

}

Smits, F, Groen, K, Levin, M-D, Stege, CAM, Kampen, RJWV, van der Spek, E, Bilgin, YM, Thielen, N, Nijhof, IS, Ludwig, I, Waal, EGMD, Sandberg, Y, Kentos, A, Timmers, GJ, Regelink, JC, Westerman, M, de Heer, K, Vekemans, MC, Durdu-Rayman, N, de Graauw, N, Seefat, MR, Donk, NWCJVD, Ypma, PF, Nasserinejad, K & Zweegman, S 2024, 'Frailty Subgroups Determine Heterogeneous Outcomes in Elderly Patients with Newly-Diagnosed Multiple Myeloma- Long-Term Follow-up of the HOVON 143 Trial', Blood, vol. 144, pp. 4739-4740. https://doi.org/10.1182/blood-2024-208754

TY - JOUR

T1 - Frailty Subgroups Determine Heterogeneous Outcomes in Elderly Patients with Newly-Diagnosed Multiple Myeloma- Long-Term Follow-up of the HOVON 143 Trial

AU - Smits, Febe

AU - Groen, Kaz

AU - Levin, Mark-David

AU - Stege, Claudia A. M.

AU - Kampen, Roel J. W. van

AU - van der Spek, Ellen

AU - Bilgin, Yavuz M.

AU - Thielen, Noortje

AU - Nijhof, Inger S.

AU - Ludwig, Inge

AU - Waal, Esther G. M. De

AU - Sandberg, Yorick

AU - Kentos, Alain

AU - Timmers, Gert Jan

AU - Regelink, Josien C.

AU - Westerman, Matthijs

AU - de Heer, Koen

AU - Vekemans, Marie Christiane

AU - Durdu-Rayman, Nazik

AU - de Graauw, Nicole

AU - Seefat, Maarten R.

AU - Donk, Niels W. C. J. van de

AU - Ypma, Paula F.

AU - Nasserinejad, Kazem

AU - Zweegman, Sonja

PY - 2024/11/5

Y1 - 2024/11/5

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:001416739600043&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1182/blood-2024-208754

DO - 10.1182/blood-2024-208754

M3 - Meeting Abstract

SN - 0006-4971

VL - 144

SP - 4739

EP - 4740

JO - Blood

JF - Blood

ER -

Frailty Subgroups Determine Heterogeneous Outcomes in Elderly Patients with Newly-Diagnosed Multiple Myeloma- Long-Term Follow-up of the HOVON 143 Trial

Access to Document

Other files and links

Cite this